Congenital Disorders of N-linked Glycosylation

Marc C. Patterson

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations


The congenital disorders of glycosylation (CDG) are a family of anabolic diseases with variable multisystem manifestations. Most of these disorders have multisystem manifestations, in addition to a wide variety of neurologic phenotypes. The most frequent type is PMM2-CDG (phosphomannomutase deficiency), which is associated with severe cerebellar atrophy, intellectual disability, stroke-like episodes and seizures, and progressive pigmentary retinopathy and demyelinating neuropathy in classic cases. Other phenotypes have considerable overlap, and with few exceptions, are accompanied by varying systemic manifestations that may include coagulopathies, gastrointestinal disease, lipodystrophy, skeletal deformities, cardiac, renal, and eye disease. CDG should be suspected in any patient with multisystem disease and neurologic manifestations, and can be efficiently screened for in most cases using carbohydrate deficient transferrin. Enzyme analysis is clinically available for the more common disorders, and molecular diagnosis is rapidly improving for all forms of CDG. Specific therapy is available for MPI-CDG and SLC365C1-CDG.

Original languageEnglish (US)
Title of host publicationRosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease
Subtitle of host publicationFifth Edition
PublisherElsevier Inc.
Number of pages14
ISBN (Electronic)9780124105294
ISBN (Print)9780124105492
StatePublished - Nov 13 2014


  • Cerebellar atrophy
  • Coagulation defects
  • Developmental delay
  • Epilepsy
  • Glycosylation
  • Intellectual disability
  • Mannose
  • Microcephaly
  • Stroke-like episodes

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Congenital Disorders of N-linked Glycosylation'. Together they form a unique fingerprint.

Cite this